The Cost Effectiveness of Collaborative Care for Depressive Disorder in the Occupational Health Setting

Conditions: depression
Major depressive disorder

Registration Number: NL-OMON30479

Lead Sponsor: Stichting Centraal Fonds RVVZ

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Pending

Sex: Not specified

Target Recruitment: 116

Inclusion Criteria

A score of 15 or higher on the PHQ9, a short questionnaire that screens for Major Depressive Episode. The patient has to resume work for 6 to 52 weeks and has no prospect yet for work resumption.

Exclusion Criteria

Patients who are suicidal, psychotic or demented, according to the company OP, will be excluded from the study (they are however referred to a doctor in case of high suicidal risk or a suggestion is given for another form of help), and also patients who are addicted to drugs or alcohol, as assessed by the MINI interview, and patients who do not have sufficient command of the Dutch language to fill in the questionnaires. Also patients who are in conflict with their employer will be excluded from the study as well as patients who are already receiving disablement insurance benefit due to MDD and patients who are pregnant. Patients with a lawsuit against their employer e.g. due to a conflict at work, will be excluded. Patients who are already receiving psychiatric treatment can be included in the study, if there is mutual agreement with their care-giver.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Primary outcome measure in this study is time to return to work, as is measured<br /><br>by inquiry with the patient and which refers to the duration of sickness<br /><br>absence until return to work. Tertiairy outcome measure is the<br /><br>cost-effectiveness of collaborative care compared to CAU. Therefore, an<br /><br>estimation of the direct medical costs and the costs due to production losses<br /><br>(productivity costs) is made. To estimate the costs the Trimbos/iMTA<br /><br>questionnaire for Costs associated with Psychiatric Illness (TiC-P) is used.<br /><br>Quality of life is assessed by the EQ-5D and the SF-36.</p><br>

Secondary Outcome Measures